THE COURSE OF BEHÇET’S DISEASE FOLLOWING COVID-19 DIAGNOSIS: A LARGE RETROSPECTIVE COHORT STUDY
Objective: Behçet’s disease (BD) is a chronic vasculitic disease with mucocutaneous and systemic involvements. This study aims to examine the effects of COVID-19 on the symptoms and course of BD. Material and Method: The BD patients who were followed up in our department with a history of COVID-19 w...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Istanbul University Press
2024-07-01
|
| Series: | İstanbul Tıp Fakültesi Dergisi |
| Subjects: | |
| Online Access: | https://cdn.istanbul.edu.tr/file/JTA6CLJ8T5/4BB5ACBEF21F440CAE3381A86691929A |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850189350021627904 |
|---|---|
| author | Tuğba Atcı Yasemin Erdem Dilay Yerlioğlu Ak Afet Akdağ Köse |
| author_facet | Tuğba Atcı Yasemin Erdem Dilay Yerlioğlu Ak Afet Akdağ Köse |
| author_sort | Tuğba Atcı |
| collection | DOAJ |
| description | Objective: Behçet’s disease (BD) is a chronic vasculitic disease with mucocutaneous and systemic involvements. This study aims to examine the effects of COVID-19 on the symptoms and course of BD. Material and Method: The BD patients who were followed up in our department with a history of COVID-19 were evaluated regarding the course of infection and the course of BD postCOVID diagnosis, assessed by Behçet’s Disease Activity Index (BDAI). Result: Among 449 BD patients, 68 (15.1%) had contracted COVID-19. The mean age of the patients was 42.7±11.8 years of whom 63.2% (n=43) were female. While most (n=48, 70.6%) had only mucocutaneous symptoms, others also had systemic symptoms (n=20, 29.4%) during their BD course; 86.8% (n=59) had received colchicine only at the time of infection. Prior to infection, 85.3% (n=58) had been in remission (BDAI score of 0), while 14.7% (n=10) already had active BD (BDAI score between 1-3). Post-COVID-19 diagnosis, activation or exacerbation of activation was seen in 39.7% (n=27) of BD patients, as characterized by increased BDAI scores (BDAI score between 1-4). No change was recorded in 60.3% (n=41) of the patients. Disease activation in the BD patients was mostly mucocutaneous (n=21, 30.9%). Comparison of the BD patients’ BDAI scores pre- and post-COVID-19 diagnosis revealed the scores to be significantly elevated (p<0.001; z=-4.691), demonstrating the possible effects of COVID-19 on BD severity.Conclusion: COVID-19 infection may lead to activation of BD symptoms, with new organs being involved in some patients, which should be confirmed by prospective large series. |
| format | Article |
| id | doaj-art-9a79be31a095486ea67693e21f71a341 |
| institution | OA Journals |
| issn | 1305-6441 |
| language | English |
| publishDate | 2024-07-01 |
| publisher | Istanbul University Press |
| record_format | Article |
| series | İstanbul Tıp Fakültesi Dergisi |
| spelling | doaj-art-9a79be31a095486ea67693e21f71a3412025-08-20T02:15:38ZengIstanbul University Pressİstanbul Tıp Fakültesi Dergisi1305-64412024-07-0187320220810.26650/IUITFD.1402339123456THE COURSE OF BEHÇET’S DISEASE FOLLOWING COVID-19 DIAGNOSIS: A LARGE RETROSPECTIVE COHORT STUDYTuğba Atcı0https://orcid.org/0000-0003-0505-3788Yasemin Erdem1https://orcid.org/0000-0002-6597-2957Dilay Yerlioğlu Ak2https://orcid.org/0000-0001-9060-4972Afet Akdağ Köse3https://orcid.org/0000-0002-7817-0363İstanbul Üniversitesi, İstanbul, Türkiyeİstanbul Üniversitesi, İstanbul, Türkiyeİstanbul Üniversitesi, İstanbul, Türkiyeİstanbul Üniversitesi, İstanbul, TürkiyeObjective: Behçet’s disease (BD) is a chronic vasculitic disease with mucocutaneous and systemic involvements. This study aims to examine the effects of COVID-19 on the symptoms and course of BD. Material and Method: The BD patients who were followed up in our department with a history of COVID-19 were evaluated regarding the course of infection and the course of BD postCOVID diagnosis, assessed by Behçet’s Disease Activity Index (BDAI). Result: Among 449 BD patients, 68 (15.1%) had contracted COVID-19. The mean age of the patients was 42.7±11.8 years of whom 63.2% (n=43) were female. While most (n=48, 70.6%) had only mucocutaneous symptoms, others also had systemic symptoms (n=20, 29.4%) during their BD course; 86.8% (n=59) had received colchicine only at the time of infection. Prior to infection, 85.3% (n=58) had been in remission (BDAI score of 0), while 14.7% (n=10) already had active BD (BDAI score between 1-3). Post-COVID-19 diagnosis, activation or exacerbation of activation was seen in 39.7% (n=27) of BD patients, as characterized by increased BDAI scores (BDAI score between 1-4). No change was recorded in 60.3% (n=41) of the patients. Disease activation in the BD patients was mostly mucocutaneous (n=21, 30.9%). Comparison of the BD patients’ BDAI scores pre- and post-COVID-19 diagnosis revealed the scores to be significantly elevated (p<0.001; z=-4.691), demonstrating the possible effects of COVID-19 on BD severity.Conclusion: COVID-19 infection may lead to activation of BD symptoms, with new organs being involved in some patients, which should be confirmed by prospective large series.https://cdn.istanbul.edu.tr/file/JTA6CLJ8T5/4BB5ACBEF21F440CAE3381A86691929Abehcet’s diseasecovid-19disease activity |
| spellingShingle | Tuğba Atcı Yasemin Erdem Dilay Yerlioğlu Ak Afet Akdağ Köse THE COURSE OF BEHÇET’S DISEASE FOLLOWING COVID-19 DIAGNOSIS: A LARGE RETROSPECTIVE COHORT STUDY İstanbul Tıp Fakültesi Dergisi behcet’s disease covid-19 disease activity |
| title | THE COURSE OF BEHÇET’S DISEASE FOLLOWING COVID-19 DIAGNOSIS: A LARGE RETROSPECTIVE COHORT STUDY |
| title_full | THE COURSE OF BEHÇET’S DISEASE FOLLOWING COVID-19 DIAGNOSIS: A LARGE RETROSPECTIVE COHORT STUDY |
| title_fullStr | THE COURSE OF BEHÇET’S DISEASE FOLLOWING COVID-19 DIAGNOSIS: A LARGE RETROSPECTIVE COHORT STUDY |
| title_full_unstemmed | THE COURSE OF BEHÇET’S DISEASE FOLLOWING COVID-19 DIAGNOSIS: A LARGE RETROSPECTIVE COHORT STUDY |
| title_short | THE COURSE OF BEHÇET’S DISEASE FOLLOWING COVID-19 DIAGNOSIS: A LARGE RETROSPECTIVE COHORT STUDY |
| title_sort | course of behcet s disease following covid 19 diagnosis a large retrospective cohort study |
| topic | behcet’s disease covid-19 disease activity |
| url | https://cdn.istanbul.edu.tr/file/JTA6CLJ8T5/4BB5ACBEF21F440CAE3381A86691929A |
| work_keys_str_mv | AT tugbaatcı thecourseofbehcetsdiseasefollowingcovid19diagnosisalargeretrospectivecohortstudy AT yaseminerdem thecourseofbehcetsdiseasefollowingcovid19diagnosisalargeretrospectivecohortstudy AT dilayyerliogluak thecourseofbehcetsdiseasefollowingcovid19diagnosisalargeretrospectivecohortstudy AT afetakdagkose thecourseofbehcetsdiseasefollowingcovid19diagnosisalargeretrospectivecohortstudy AT tugbaatcı courseofbehcetsdiseasefollowingcovid19diagnosisalargeretrospectivecohortstudy AT yaseminerdem courseofbehcetsdiseasefollowingcovid19diagnosisalargeretrospectivecohortstudy AT dilayyerliogluak courseofbehcetsdiseasefollowingcovid19diagnosisalargeretrospectivecohortstudy AT afetakdagkose courseofbehcetsdiseasefollowingcovid19diagnosisalargeretrospectivecohortstudy |